150 results
10-K/A
2015 FY
LRMR
Larimar Therapeutics Inc
29 Apr 16
Annual report (amended)
12:00am
(available at http://www.zafgen.com/) and/or in our public filings with the SEC.
Audit Committee
Our Board of Directors has a separately-designated … Audit Committee. Frances K. Heller, John L. LaMattina, Ph.D. and Frank E. Thomas serve on the Audit Committee, which is chaired by Mr. Thomas. Our Board
PRE 14A
asqef6
12 Apr 24
Preliminary proxy
6:06am
8-K
ltcso95hxnbvxs2 8pmd
7 Jun 18
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
5:06pm
PREM14A
f951vj3
6 Mar 20
Preliminary proxy related to merger
5:32pm
DEFM14A
753r0r4641ixw46o2c
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
hhpnphwrwjonld
10 Apr 20
Preliminary revised proxy
4:38pm
8-K
EX-14.1
gd7hnaxvx d3lyhwy
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-99.1
x4yp5 tp4r9oz4r
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm